IDXX - IDEXX Laboratories GAAP EPS of $2.55 beats by $0.17 revenue of $900M beats by $9.4M
2023-05-02 06:33:12 ET
- IDEXX Laboratories press release ( NASDAQ: IDXX ): Q1 GAAP EPS of $2.55 beats by $0.17 .
- Revenue of $900M (+7.6% Y/Y) beats by $9.4M .
- Increases 2023 revenue guidance to $3,615 million - $3,700 million, reflecting 7.5% - 10% growth as reported and organically.
- Updates 2023 EPS outlook to $9.33 - $9.75, a year-over-year increase of 16% - 22% as reported and 20% - 26% on a comparable basis, including ~12% combined growth benefit from a customer contract resolution payment in Q1 2023 and lapping of discrete 2022 R&D investments
For further details see:
IDEXX Laboratories GAAP EPS of $2.55 beats by $0.17, revenue of $900M beats by $9.4M